解放军医学杂志
解放軍醫學雜誌
해방군의학잡지
MEDICAL JOURNAL OF CHINESE PEOPLE'S LIBERATION ARMY
2001年
2期
117-118
,共2页
胃肿瘤%白血病%药物
胃腫瘤%白血病%藥物
위종류%백혈병%약물
在相同条件下,通过测定细胞死亡率、DNA电泳、末端脱氧核苷转移酶介导的生物素标记寡核苷酸末端标记(TUNEL),对比观察足叶已甙(VP-16)作用下人胃低分化腺癌细胞(BGS-180 )和慢性淋巴细胞性白血病细胞(HL-60)的凋亡情况。结果显示,低剂量VP-16短时间作用HL-60细胞,细胞的死亡以凋亡为主,并可被蛋白激酶C(PKC)激活所抑制;而VP-16致BGS-180 细胞的死亡以坏死为主,不被PKC所抑制。细胞外Ca2+螯合剂EDTA对VP-16作用下两种细胞的死亡无影响。提示化疗药对HL-60细胞和BGS-180细胞的作用机制不同,在其导致BGS-180细胞的死亡中凋亡并不是主要的方式。
在相同條件下,通過測定細胞死亡率、DNA電泳、末耑脫氧覈苷轉移酶介導的生物素標記寡覈苷痠末耑標記(TUNEL),對比觀察足葉已甙(VP-16)作用下人胃低分化腺癌細胞(BGS-180 )和慢性淋巴細胞性白血病細胞(HL-60)的凋亡情況。結果顯示,低劑量VP-16短時間作用HL-60細胞,細胞的死亡以凋亡為主,併可被蛋白激酶C(PKC)激活所抑製;而VP-16緻BGS-180 細胞的死亡以壞死為主,不被PKC所抑製。細胞外Ca2+螯閤劑EDTA對VP-16作用下兩種細胞的死亡無影響。提示化療藥對HL-60細胞和BGS-180細胞的作用機製不同,在其導緻BGS-180細胞的死亡中凋亡併不是主要的方式。
재상동조건하,통과측정세포사망솔、DNA전영、말단탈양핵감전이매개도적생물소표기과핵감산말단표기(TUNEL),대비관찰족협이대(VP-16)작용하인위저분화선암세포(BGS-180 )화만성림파세포성백혈병세포(HL-60)적조망정황。결과현시,저제량VP-16단시간작용HL-60세포,세포적사망이조망위주,병가피단백격매C(PKC)격활소억제;이VP-16치BGS-180 세포적사망이배사위주,불피PKC소억제。세포외Ca2+오합제EDTA대VP-16작용하량충세포적사망무영향。제시화료약대HL-60세포화BGS-180세포적작용궤제불동,재기도치BGS-180세포적사망중조망병불시주요적방식。
Programmed cell death(PCD)of human leukemic HL-60 cell and human poorly differentiated gastric adenocarcinoma cell BGS-180 induced by efoposid(VP-16) was preliminarily observed comparatively in the same experimental condition through rate of cell death, DNA agarose gels electrophoresis and terminal deoxynucleotidyl transferase(TdT) mediated biotin-11-dUTP nickend labeling(TUNEL).It was found that apoptosis is the main pattern of HL-60 cell death induced by low does VP-16 in a short time, and it can be suppressed when protein kinase C(PKC) is activated. The main pattern of BGS-180 cell death induced by VP-16 is necrosis, and PCK activation does not affect its necrosis rate. Extracellular Ca2+ reduction do not affect BGS-180 and HL-60 cell death rate. The mechanism of VP-16 action on BGS-180 and HL-60 cell is different, apoptosis is not the main pattern of cell BGS-180 death induced by VP-16.